Concentration of Lipid, Apoprotein-B and Testosterone in Patients with Coronarographic Findings

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1985 Oct 15

PMID 4068611

Citations 3

Authors

M Hromadova

T HACIK

I Riecansky

Affiliations

Soon will be listed here.

Abstract

The relationship between lipid, apolipoprotein-B and testosterone concentration and indicated coronarography was followed in male patients assigned into two age groups (under and over 50 years). Patients without a positive finding on coronary vessels served as controls. Patients of both age groups with a positive coronarographic finding showed an enhanced apolipoprotein-B and a decreased cholesterol concentration in the HDL2-high density lipoprotein subfraction. Likewise, testosterone level was also decreased in the two age groups. It appears that a lowered testosterone level may indirectly intervene into lipoprotein metabolism, or may affect the apolipoprotein-B level.

Citing Articles

Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Cattabiani C, Basaria S, Ceda G, Luci M, Vignali A, Lauretani F J Endocrinol Invest. 2011; 35(1):104-20.

PMID: 22082684 DOI: 10.3275/8061.

Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment.

Hromadova M, HACIK T, Malatinsky E, SKLOVSKY A, Cervenakov J, LABADY F Int Urol Nephrol. 1991; 23(1):69-75.

PMID: 1938220 DOI: 10.1007/BF02549731.

Sex hormone concentrations in men with angiographically assessed coronary artery disease--relationship to obesity and body fat distribution.

Hauner H, Stangl K, Burger K, Busch U, Blomer H, Pfeiffer E Klin Wochenschr. 1991; 69(14):664-8.

PMID: 1836242 DOI: 10.1007/BF01649428.

References

Phillips G . Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A. 1977; 74(4):1729-33. PMC: 430867. DOI: 10.1073/pnas.74.4.1729. View

Dannel W . The role of cholesterol in coronary atherogenesis. Med Clin North Am. 1974; 58(2):363-79. View

Sebokova E, Kolena J . Characterization of specific prostaglandin E receptor in isolated rat Leydig cells. Endocrinol Exp. 1978; 12(3):147-56. View

Rudel L, Morris M . Determination of cholesterol using o-phthalaldehyde. J Lipid Res. 1973; 14(3):364-6. View

Mertz D . [Vasoprotective and vasoaggressive characteristics of serum lipoproteins]. MMW Munch Med Wochenschr. 1978; 120(50):1671-2. View

NORDOY A, AAKVAAG A, Thelle D . Sex hormones and high density lipoproteins in healthy males. Atherosclerosis. 1979; 34(4):431-6. DOI: 10.1016/0021-9150(79)90067-4. View

Chait A, Albers J, Brunzell J . Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest. 1980; 10(1):17-22. DOI: 10.1111/j.1365-2362.1980.tb00004.x. View

Mendoza S, Osuna A, Zerpa A, Gartside P, Glueck C . Hypertriglyceridemia and hypoalphalipoproteinemia in azoospermic and oligospermic young men: relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism. Metabolism. 1981; 30(5):481-6. DOI: 10.1016/0026-0495(81)90184-0. View

Reuter W . [Secondary hyperlipoproteinemias]. Z Gesamte Inn Med. 1978; 33(22):817-22. View

10.

Hazzard W, Kushwaha R, Haffner S, Steinmetz A, Foster D . Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia. Metabolism. 1984; 33(10):873-81. DOI: 10.1016/0026-0495(84)90239-7. View

11.

Carlson L . DETERMINATION OF SERUM TRIGLYCERIDES. J Atheroscler Res. 1963; 3:334-6. DOI: 10.1016/s0368-1319(63)80012-5. View

12.

Haffner S, Kushwaha R, Foster D, Hazzard W . Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism. 1983; 32(4):413-20. DOI: 10.1016/0026-0495(83)90052-5. View

13.

Curry M, Gustafson A, Alaupovic P, McConathy W . Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem. 1978; 24(2):280-6. View

14.

WHAYNE T, Alaupovic P, Curry M, Lee E, Anderson P, Schechter E . Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis. 1981; 39(3):411-24. DOI: 10.1016/0021-9150(81)90026-5. View

15.

Vander Heiden G, Barboriak J, SASSE E, Yorde D . Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B. Atherosclerosis. 1984; 50(1):29-33. DOI: 10.1016/0021-9150(84)90005-4. View

16.

SOLYOM A . Effect of androgens on serum lipids and lipoproteins. Lipids. 1972; 7(2):100-5. DOI: 10.1007/BF02532595. View

17.

Gutai J, Laporte R, Kuller L, Dai W, Caggiula A . Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol. 1981; 48(5):897-902. DOI: 10.1016/0002-9149(81)90356-8. View

18.

Mertz D . ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders]. Med Klin. 1980; 75(4):159-61. View

19.

Goldstein J, Brown M . The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977; 46:897-930. DOI: 10.1146/annurev.bi.46.070177.004341. View

20.

Glueck C, Scheel D, FISHBACK J, Steiner P . Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes. Lipids. 1972; 7(2):110-3. DOI: 10.1007/BF02532597. View